Acelyrin Inc (SLRN)
4.68
-0.20
(-4.10%)
USD |
NASDAQ |
May 10, 16:00
4.97
+0.29
(+6.20%)
After-Hours: 07:45
Acelyrin Total Assets (Quarterly): 742.69M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 742.69M |
| September 30, 2023 | 800.49M |
| June 30, 2023 | 835.13M |
| Date | Value |
|---|---|
| March 31, 2023 | 298.52M |
| December 31, 2022 | 319.92M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
298.52M
Minimum
Mar 2023
835.13M
Maximum
Jun 2023
599.35M
Average
742.69M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| Lexicon Pharmaceuticals Inc | 417.22M |
| Eagle Pharmaceuticals Inc | 404.82M |
| Avalo Therapeutics Inc | 20.99M |
| Design Therapeutics Inc | 289.64M |
| CEL-SCI Corp | 28.71M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 86.35M |
| Shareholders Equity (Quarterly) | 656.34M |